90 related articles for article (PubMed ID: 29569965)
21. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
Meng K; Luo H; Chen H; Guo H; Xia W
Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
[TBL] [Abstract][Full Text] [Related]
22. Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update.
Liu S; Zhao H; Li X
Cancer Manag Res; 2024; 16():299-310. PubMed ID: 38617188
[TBL] [Abstract][Full Text] [Related]
23. Machine Learning for Predicting Distant Metastasis of Medullary Thyroid Carcinoma Using the SEER Database.
Guo ZT; Tian K; Xie XY; Zhang YH; Fang DB
Int J Endocrinol; 2023; 2023():9965578. PubMed ID: 38186857
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract][Full Text] [Related]
25. Combination of ultrasound and serological tests for detecting occult lateral lymph node metastases in medullary thyroid cancer.
Xiao J; Jiang J; Chen W; Hong T; Li B; He X; Liu W
Cancer Med; 2023 May; 12(10):11417-11426. PubMed ID: 37004158
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Profile of Medullary Thyroid Carcinoma-Could We Predict Aggressive Behavior?
Giusca SE; Andriescu EC; Caruntu ID; Ciobanu D
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672624
[TBL] [Abstract][Full Text] [Related]
27. Nomogram for preoperative estimation risk of cervical lymph node metastasis in medullary thyroid carcinoma.
Luo Z; Hong Y; Yan C; Ye Q; Wang Y; Huang P
Front Oncol; 2022; 12():883429. PubMed ID: 36313643
[TBL] [Abstract][Full Text] [Related]
28. Management of lymph nodes in medullary thyroid carcinoma: A review.
Shaghaghi A; Salari A; Jalaeefar A; Shirkhoda M
Ann Med Surg (Lond); 2022 Sep; 81():104538. PubMed ID: 36147070
[TBL] [Abstract][Full Text] [Related]
29. A Predictive Model for the 10-year Overall Survival Status of Patients With Distant Metastases From Differentiated Thyroid Cancer Using XGBoost Algorithm-A Population-Based Analysis.
Jin S; Yang X; Zhong Q; Liu X; Zheng T; Zhu L; Yang J
Front Genet; 2022; 13():896805. PubMed ID: 35873493
[No Abstract] [Full Text] [Related]
30. Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis.
Cao ZX; Weng X; Huang JS; Long X
Updates Surg; 2022 Oct; 74(5):1551-1562. PubMed ID: 35821560
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for lateral cervical lymph node metastasis in medullary thyroid carcinoma.
Wu F; Zhou T; Lu K; Pan T; Ni Y; Zhao L; Jiang K; Zhang Y; Luo D
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):730-740. PubMed ID: 35347916
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes.
Fan Y; Xu H; Lv M; Li N
Dis Markers; 2022; 2022():9980185. PubMed ID: 35280443
[TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.
Wu X; Li B; Zheng C
Technol Cancer Res Treat; 2022; 21():15330338221078435. PubMed ID: 35188853
[No Abstract] [Full Text] [Related]
34. The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma.
Zhou TH; Zhao LQ; Zhang Y; Wu F; Lu KN; Mao LL; Jiang KC; Luo DC
Front Endocrinol (Lausanne); 2021; 12():741289. PubMed ID: 34867784
[TBL] [Abstract][Full Text] [Related]
35. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC).
Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296
[No Abstract] [Full Text] [Related]
36. Lymph node metastases in pediatric medullary thyroid carcinoma.
Oliver JR; Patel KN; Chang CM; Baldwin CK; Brar PC; Morris LGT; Givi B
Surgery; 2021 Sep; 170(3):736-742. PubMed ID: 33838880
[TBL] [Abstract][Full Text] [Related]
37. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
[TBL] [Abstract][Full Text] [Related]
38. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.
Fan W; Xiao C; Wu F
J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
Wu X; Li B; Zheng C; Liu W; Hong T; He X
Technol Cancer Res Treat; 2020; 19():1533033820962089. PubMed ID: 32964812
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
